Nuria Romero-Laorden
Hospital Universitario de La Princesa(ES)Roche (Spain)(ES)Universidad Autónoma de Madrid(ES)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology
Most-Cited Works
- → PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer(2019)367 cited
- → Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients(2019)257 cited
- → A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families(2015)161 cited
- → When should we order a next generation sequencing test in a patient with cancer?(2020)157 cited
- → Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis(2013)134 cited
- → Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer(2018)80 cited